Baxter Announces Quarterly Dividend and Expanded Share Repurchase Authorization

Baxter International Inc., a leading global medical products company, announced a quarterly cash dividend and an expanded authorization for its share repurchase program. The Board of Directors of Baxter has declared a quarterly cash dividend of USD 0.19 per share of common stock, payable on Jan. 2, 2019, to stockholders of record as of Dec. 3, 2018. The indicated annual dividend rate is USD 0.76 per share of common stock.

Baxter’s Board of Directors has also approved a USD 2.0 billion increase in authorization for the company’s existing share repurchase plan. Based on these actions, the share repurchase plan has approximately USD 3.4 billion of repurchase authority available as of the date hereof to make repurchases pursuant to new or existing Rule 10b5-1 plans or otherwise. Shares will be repurchased in the open market or through private transactions at times and amounts determined by the company based on its evaluation of market conditions and other factors and, if applicable, in accordance with the terms of one or more Rule 10b5-1 plans.

“Baxter’s strong balance sheet allows us to serve our shareholders by investing in growth as well as returning value through dividends and share repurchases,” said Jay Saccaro, Baxter’s chief financial officer. – Medical Buyer Bureau